A Shared Haplotype Indicates a Founder Event in Unverricht–Lundborg Disease Patients from Serbia

References

• Kälviäinen R, Khyuppenen J, Koskenkorva P, Clinical picture of EPM1-Unverricht–Lundborg disease. Epilepsia 2008;49:549–56.
   Google Scholar
• Genton P, Michelucci R, Tassinari CA, The Ramsay Hunt syndrome revisited: mediterranean myoclonus versus mitochondrial encephalomyopathy with ragged-red fibers and Baltic myoclonus. Acta Neurol Scand 1990;81:8–15.
   PubMed Web of Science ®Google Scholar
• Gouider R, Ibrahim S, Fredj M, Unverricht–Lündborg disease: clinical and electrophysiologic study of 19 Maghreb families. Rev Neurol (Paris) 1998;154:503–7.
   Google Scholar
• Moulard B, Genton P, Grid D, Haplotype study of West European and North African Unverricht–Lundborg chromosomes: evidence for a few founder mutations. Hum Genet 2002;111:255–62.
   Google Scholar
• Kyllerman M, Sommerfelt K, Hedström A, Clinical and neurophysiological development of Unverricht–Lundborg disease in four Swedish siblings. Epilepsia 1999;32:900–9.
   Google Scholar
• Shakir RA, Khan RA, al-Zuhair AG. Progressive myoclonic ataxia without ragged red fibres: Unverricht–Lundborg disease vs Ramsay Hunt syndrome. Acta Neurol Scand 1992;86:470–3.
   Google Scholar
• Acharya JN, Satishchandra P, Shankar SK. Familial progressive myoclonus epilepsy: clinical and electrophysiologic observations. Epilepsia 1995;36:429–34.
   Google Scholar
• Parmeggiani A, Lehesjoki AE, Carelli V, Familial Unverricht–Lundborg disease: a clinical, neurophysiologic, and genetic study. Epilepsia 1997;38:637–41.
   Google Scholar
• Vistorte A, Sardiñas N, Esteban EM, Progressive myoclonic epilepsy: clinical characteristics of 18 patients. Rev Neurol 1999;29:102–4.
   Google Scholar
• Mazarib A, Xiong L, Neufeld MY, Unverricht–Lundborg disease in a five-generation Arab family: instability of dodecamer repeats. Neurology 2001;57:1050–4.
   Google Scholar
• Pennacchio LA, Lehesjoki AE, Stone NE, Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 1996;271:1731–34.
   PubMed Web of Science ®Google Scholar
• Lafrenière RG, Rochefort DL, Chrétien N, Unstable insertion in the 5’ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet 1997;15:298–302.
   PubMed Web of Science ®Google Scholar
• Lalioti MD, Scott HS, Buresi C, Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 1997;386:847–51.
   PubMed Web of Science ®Google Scholar
• Virtaneva K, D'Amato E, Miao J, Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet 1997;15:393–6.
   PubMed Web of Science ®Google Scholar
• Lalioti MD, Scott HS, Genton P, A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset. Am J Hum Genet. 1998;62:842–7.
   PubMed Web of Science ®Google Scholar
• Horiuchi H, Osawa M, Furutani R, Polymerase chain reaction-based analysis using deaminated DNA of dodecamer expansions in CSTB, associated with Unverricht–Lundborg myoclonus epilepsy. Genet Test 2005;9:328–33.
   Google Scholar
• Larson GP, Ding S, Lafrenière RG, Instability of the EPM1 minisatellite. Hum Mol Genet 1999;8:1985–8.
   Google Scholar
• Weinhaeusel A, Morris MA, Antonarakis SE, DNA deamination enables direct PCR amplification of the cystatin B (CSTB) gene-associated dodecamer repeat expansion in myoclonus epilepsy type Unverricht–Lundborg. Hum Mutat 2003;22:404–8.
   PubMedGoogle Scholar
• Joensuu T, Kuronen M, Alakurtti K, Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht–Lundborg type (EPM1) patients. Eur J Hum Genet 2007;15:185–93.
   Google Scholar
• Hamdan H, Tynan JA, Fenwick RA, Automated detection of Trinucleotide repeats in fragile X syndrome. Mol Diagn 1997;2:259–69.
   PubMedGoogle Scholar
• Houdayer C, Lemonnier A, Gerard M, Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus. Clin Chem Lab Med 1999; 37:397–402.
   PubMed Web of Science ®Google Scholar
• Hećimović S, Vlasić J, Barisić L, A simple and rapid analysis of triplet repeat diseases by expand long PCR. Clin Chem Lab Med 2001;39:1259–62.
   PubMed Web of Science ®Google Scholar
• Saluto A, Brussino A, Tassone F, An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene. J Mol Diagn 2005;7:605–12.
   PubMed Web of Science ®Google Scholar
• Barbujani G, Bertorelle G. Genetics and the population history of Europe. Proc Natl Acad Sci U S A 2001;98:22–5.
   PubMed Web of Science ®Google Scholar
• Cavalli-Sforza LL. The DNA revolution in population genetics. Trends Genet 1998;14:60–5. Review.
   PubMed Web of Science ®Google Scholar
• Behar DM, Rosset S, Blue-Smith J, , Genographic consortium. The genographic project public participation mitochondrial DNA database. PLoS Genet 2007;3:e104. Erratum in: PLoS Genet. 3:1785
   Google Scholar
• Dibbens LM, Michelucci R, Gambardella A, SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure. Ann Neurol 2009;66:532–6.
   Google Scholar
• Bassuk AG, Wallace RH, Buhr A, A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am J Hum Genet 2008;83:572–81.
   PubMed Web of Science ®Google Scholar
• Corbett MA, Schwake M, Bahlo M, A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia. Am J Hum Genet 2011;88:657–63.
   Google Scholar
• Kecmanović M, Ristić AJ, Sokić D, Coexistence of Unverricht–Lundborg disease and congenital deafness: molecular resolution of a complex comorbidity. Epilepsia 2009;50:1612–5.
   Google Scholar